2315

HKSE:2315

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Stock

HKD

Last Close

6.37

30/08 07:58

Market Cap

3.05B

Beta: -

Volume Today

153K

Avg: 161.05K

PE Ratio

−7.72

PFCF: −5.73

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '20	Dec '21	Dec '22	Dec '23
account payables	87.60M -	102.44M 16.94%	146.19M 42.71%	175.23M 19.87%
accumulated other comprehensive income loss				386.49M -
cash and cash equivalents	750.04M -	466.44M 37.81%	603.07M 29.29%	417.66M 30.74%
cash and short term investments	950.04M -	566.45M 40.38%	611.27M 7.91%	426.14M 30.29%
common stock	360M -	374.93M 4.15%	399.40M 6.53%	399.40M 0%
deferred revenue
deferred revenue non current	90.12M -	92.80M 2.97%	89.93M 3.09%
deferrred tax liabilities non current
goodwill
goodwill and intangible assets	2.43M -	6.05M 149.38%	30.65M 406.23%	28.13M 8.23%
intangible assets	2.43M -	6.05M 149.38%	30.65M 406.23%	28.13M 8.23%
inventory	7.98M -	15.14M 89.72%	95.10M 528.15%	7.42M 92.20%
long term debt	449.69M -	511.46M 13.73%	243.68M 52.36%	340.91M 39.90%
long term investments	-189.91M -	-90.31M 52.44%	242.61M 368.62%	247.40M 1.98%
net debt	-286.25M -	71.91M 125.12%	-187.79M 361.15%	100.09M 153.30%
net receivables	135.77M -	224.52M 65.37%	136.43M 39.24%	142.38M 4.37%
other assets
other current assets	53.84M -	68.13M 26.53%	76.50M 12.28%	147.11M 92.30%
other current liabilities	226.76M -	317.22M 39.89%	288.25M 9.13%	225.55M 21.75%
other liabilities
other non current assets	230.77M -	121.86M 47.20%	250.81M 105.81%
other non current liabilities			709.36M -	740.45M 4.38%
othertotal stockholders equity	1.09B -	872.28M 20.22%	2.15B 146.61%	1 100.00%
preferred stock
property plant equipment net	1.14B -	1.39B 22.49%	1.60B 14.96%	1.45B 9.27%
retained earnings			-1.40B -
short term debt	14.11M -	26.90M 90.68%	171.60M 538.00%	176.84M 3.05%
short term investments	200M -	100M 50%	8.20M 91.80%	8.49M 3.53%
tax assets			-242.61M -
tax payables	1.42M -	5.01M 254.42%	4.20M 16.35%
total assets	2.33B -	2.30B 1.02%	2.80B 21.58%	2.45B 12.52%
total current assets	1.15B -	874.24M 23.82%	919.30M 5.15%	723.05M 21.35%
total current liabilities	328.46M -	446.56M 35.95%	606.05M 35.71%	577.62M 4.69%
total debt	463.80M -	538.35M 16.08%	415.28M 22.86%	517.74M 24.67%
total investments	10.09M -	9.69M 3.99%	250.81M 2,489.62%	255.89M 2.03%
total liabilities	868.28M -	1.05B 21.02%	1.65B 56.93%	1.66B 0.60%
total liabilities and stockholders equity	2.33B -	2.30B 1.02%	2.80B 21.58%	2.45B 12.52%
total non current assets	1.18B -	1.43B 21.18%	1.88B 31.64%	1.73B 8.20%
total non current liabilities	539.81M -	604.25M 11.94%	1.04B 72.60%	1.08B 3.68%
total stockholders equity	1.45B -	1.25B 14.19%	1.15B 8.09%	785.89M 31.44%

All numbers in HKD (except ratios and percentages)